Family · Pharmaceutical analytical standards
Esaxerenone
A non-steroidal mineralocorticoid receptor antagonist that blocks the action of aldosterone: it was first approved in Japan in January 2019 for the treatment of high blood pressure. This family brings together the active ingredient and labelled standards.
Did you know?Although it belongs to the same family as spironolactone and eplerenone, it has no steroid skeleton, and it is more than a thousand times more selective for the mineralocorticoid receptor than for other steroid hormone receptors.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
